Literature DB >> 17708624

The efficacy of Chinese medicine for SARS: a review of Chinese publications after the crisis.

Ping-Chung Leung1.   

Abstract

During the SARS crisis in China, 40-60% infected patients, at some stages of their treatment, received Chinese medicine treatment on top of the standard modern medicine treatment. This practice was endorsed and encouraged by the Chinese Center for Disease Control and Prevention, and some details of the herbal treatment were recommended. A review of the publications during and after the SARS crisis enabled us to get an objective view of the true value of the adjuvant therapy using Chinese medicinal herbs. Of the 130 articles searched, 90 were of reasonable quality and contained sufficient information for the enlightenment of the situation. These were reviewed. The results revealed positive but inconclusive indications about the efficacy of the combined treatments using Chinese medicine as an adjuvant. Positive effects using adjuvant herbal therapy included better control of fever, quicker clearance of chest infection, lesser consumption of steroids and other symptoms relief. In a few reports, some evidences of immunological boosterings were also found. More caution is required on the allegation about the efficacy of herbal medicine for the treatment or prevention of viral infection affecting the respiratory tract, while more clinical studies are indicated.

Entities:  

Mesh:

Year:  2007        PMID: 17708624     DOI: 10.1142/S0192415X07005077

Source DB:  PubMed          Journal:  Am J Chin Med        ISSN: 0192-415X            Impact factor:   4.667


  28 in total

Review 1.  COVID-19: Is There Evidence for the Use of Herbal Medicines as Adjuvant Symptomatic Therapy?

Authors:  Dâmaris Silveira; Jose Maria Prieto-Garcia; Fabio Boylan; Omar Estrada; Yris Maria Fonseca-Bazzo; Claudia Masrouah Jamal; Pérola Oliveira Magalhães; Edson Oliveira Pereira; Michal Tomczyk; Michael Heinrich
Journal:  Front Pharmacol       Date:  2020-09-23       Impact factor: 5.810

2.  Perceived Quality of Traditional Chinese Medicine Care in Community Health Services: A Cross-Sectional Survey in Hangzhou of China.

Authors:  Xinyu Zhang; Jianping Ren; Liqi Sun; Chaojie Liu
Journal:  Evid Based Complement Alternat Med       Date:  2022-07-11       Impact factor: 2.650

Review 3.  Traditional Chinese medicine treatment for COVID-19: An overview of systematic reviews and meta-analyses.

Authors:  Han-Ting Wu; Cong-Hua Ji; Rong-Chen Dai; Pei-Jie Hei; Juan Liang; Xia-Qiu Wu; Qiu-Shuang Li; Jun-Chao Yang; Wei Mao; Qing Guo
Journal:  J Integr Med       Date:  2022-06-24

4.  Potential role of ginseng in the treatment of colorectal cancer.

Authors:  Chong-Zhi Wang; Chun-Su Yuan
Journal:  Am J Chin Med       Date:  2008       Impact factor: 4.667

Review 5.  Chinese herbs combined with Western medicine for severe acute respiratory syndrome (SARS).

Authors:  Xuemei Liu; Mingming Zhang; Lin He; Youping Li
Journal:  Cochrane Database Syst Rev       Date:  2012-10-17

Review 6.  Therapeutic Potentials of Antiviral Plants Used in Traditional African Medicine With COVID-19 in Focus: A Nigerian Perspective.

Authors:  Alfred Francis Attah; Adeshola Adebayo Fagbemi; Olujide Olubiyi; Hannah Dada-Adegbola; Akinseinde Oluwadotun; Anthony Elujoba; Chinedum Peace Babalola
Journal:  Front Pharmacol       Date:  2021-04-26       Impact factor: 5.810

7.  Efficacy of traditional herbal medicine for psychological sequelae in COVID-19 survivors: A protocol for systematic review and meta-analysis.

Authors:  Eunjin Kim; Jungyoon Choi; Sang Yeon Min; Ji Hwan Kim; Aram Jeong
Journal:  Medicine (Baltimore)       Date:  2021-05-21       Impact factor: 1.817

8.  Traditional chinese medicine diagnosis "yang-xu zheng": significant prognostic predictor for patients with severe sepsis and septic shock.

Authors:  Sunny Jui-Shan Lin; Yung-Yen Cheng; Chih-Hung Chang; Cheng-Hung Lee; Yi-Chia Huang; Yi-Chang Su
Journal:  Evid Based Complement Alternat Med       Date:  2013-10-24       Impact factor: 2.629

9.  Complementary and alternative medicine use among outpatients during the 2015 MERS outbreak in South Korea: a cross-sectional study.

Authors:  Jung Hye Hwang; Hyun Jeong Cho; Hyea Bin Im; Young Sun Jung; Soo Jeung Choi; Dongwoon Han
Journal:  BMC Complement Med Ther       Date:  2020-05-13

Review 10.  SWOT analysis and revelation in traditional Chinese medicine internationalization.

Authors:  Haitao Tang; Wenlong Huang; Jimei Ma; Li Liu
Journal:  Chin Med       Date:  2018-01-25       Impact factor: 5.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.